“Multiple European countries have suspended the use of AstraZeneca’s COVID-19 vaccine while investigators look into cases of blood clots among vaccinated people.” [Source: businessinsider.com]
The risk of blood clots is but one of many potential risks of COVID-19 vaccines. Looking at another potential risk, a recent study published in the International Journal of Clinical Practice (IJCP) examined whether sufficient literature exists to require clinicians to disclose that receiving COVID-19 vaccines could sensitize people to more severe viral disease than if they were not vaccinated.
Finding that adequate communication of this risk is unlikely to occur, the study stated it should be prominently disclosed to people taking part in COVID-19 vaccine trials as well as those vaccinated following regulatory approval. The study concluded that a specific, separate, informed consent form and demonstration of patient understanding of this risk is necessary in order to meet medical ethics standards.
To learn more about this highly revealing IJCP study, read this article on our website.